rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Dr Reddyrsquo

Rediff.com  »  News  »   Dr Reddyrsquo

  News for Dr Reddyrsquo

  • News
  • Business
  • Movies

Covid vaccine could cost up to Rs 1000 in private market

While the Indian government has been procuring Covid-19 vaccines at low prices so far, manufacturers have to declare the prices of vaccines they would supply to the open market (industries, private......

Expert panel seeks more data on Sputnik V Covid vaccine

‘No approval was given to Sputnik V on Thursday. Some queries have been asked on safety, efficacy, and logistics, which the firm will have answers to at the next meeting’ IMAGE:......

Sputnik V vaccine may be added to India's Covid armoury soon

‘We expect to get the approval in the next few weeks,’ says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy’s Laboratories (DRL). IMAGE: Medics administer the first......

COVID-19 vaccines likely to have longer shelf life

A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval,......

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With more drugmakers in line to launch the drug soon, the prices may see a further erosion. Sohini Das reports. IMAGE: An......

Domestic pharma market grew by 6.8% in 2023

The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. Photograph: Amit......

Cipla on the block: Who's a better fit and what it means for shareholders?

India’s third-largest pharmaceutical company by revenue, Cipla, is up for grabs in a three-way fight between Torrent Pharmaceuticals, Dr Reddy’s Laboratories (DRL) and private equity......

India's pharma industry likely to take 5-6% price hikes this year

Notwithstanding the fact that the country’s pharmaceutical (pharma) pricing regulator has allowed a 12 per cent price increase for medicines listed under the National List of Essential......

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Trade generic drugs (medicines that are sold directly through distributors) are fast becoming a key segment for domestic pharma firms as volume growth slows in the overall market. Image used for......

US drug shortage, stable pricing set to boost pharma revenues

An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India’s pharmaceutical companies during the first quarter of this financial......

Review: Azhar is a bland, badly-set souffl of Bollywood tropes without a soul

Who was Mohammad Azharuddin? More crucially, *what* was he? Those are precisely the questions that, as the end credits roll after 132 minutes of run-time, remain unanswered, feels......

Top Coverage News


World Test Championship 2023

India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

Here are news, updates and coverage from violence hit Manipur.

IPL 2023

Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z